April 28, 2017

[San Diego area] Are You Taking Prescription Warfarin or Coumadin?

Accriva Diagnostics, Inc. conducts evaluations of different blood analyzers. If you are currently taking Warfarin or Coumadin, you may qualify to participate in a study. Just 30 minutes of your time in a relaxed and friendly environment will be necessary to take the blood sample(s) from a vein in your arm. Each donor will be […]

ESC: New Anticoagulant, Edoxaban, Safer Than Warfarin

We’re finally getting a glimpse into what to expect from edoxaban, the 4th new anticoagulant medication. At the European Society of Cardiology in Amsterdam, it was reported that edoxaban was safer–in other words, had less bleeding–than warfarin for those with deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the […]

ESC: Women with atrial fibrillation are undertreated by GPs

This confirms what we already knew… As reported today at the European Society of Cardiology in Amsterdam: “Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of […]

Top Atrial Fibrillation (Afib) Articles of 2012

StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Articles of 2012. There were many topics of interest this year to the atrial fibrillation patient community. As always, the top interest was atrial fibrillation stroke prevention — that included the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for anticoagulants, the HAS-BLED tool […]

Do you have atrial fibrillation? Your input can help shape research to benefit afib patients.

Patients with atrial fibrillation are at higher risk of suffering stroke and other complications related to the development of blood clots in their heart. Until 2010, the only oral anticoagulant (blood thinner) to prevent strokes in Afib was warfarin (Coumadin®). Now there are two new oral anticoagulants available in the United States–dabigatran (Pradaxa®) and rivaroxaban […]

Why You Shouldn’t Use Aspirin for Atrial Fibrillation Stroke Prevention — Video with Dr. Waldo

At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. […]

Atrial Fibrillation, Stroke Prevention, & Aspirin Use — StopAfib.org interviews Dr. Albert Waldo

StopAfib.org interviews Dr. Albert Waldo of Case Western Reserve University Find more information on this topic, and Dr. Waldo, at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. Albert Waldo, one of the world’s foremost atrial fibrillation treatment experts, discusses why aspirin no longer plays a role in

Vote Yes to Ask the FDA to List Vitamin K on Food Labels

At the American College of Cardiology meeting last week, I discovered a neat project being tackled by Alere, the sponsor of PTINR.com, which is a web site we highly recommend for those taking Coumadin or warfarin. If you take warfarin or Coumadin, you know that you have to keep your vitamin K intake consistent, but […]

Atrial Fibrillation & Anticoagulants–StopAfib.org interviews Dr. Daniel Singer

StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: http://www.stopafib.org/newsitem.cfm/NEWSID/397 Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban […]

Update on Atrial Fibrillation Stroke Prevention — Video interview with Dr. Daniel Singer of Harvard

In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the […]